Novel imidazolides and their use as curing agents for polyepoxide
compounds
    51.
    发明授权
    Novel imidazolides and their use as curing agents for polyepoxide compounds 失效
    新型咪唑类及其作为聚环氧化物化合物固化剂的用途

    公开(公告)号:US4587311A

    公开(公告)日:1986-05-06

    申请号:US602260

    申请日:1984-04-20

    CPC分类号: C07D233/54 C08G59/44

    摘要: There are described novel imidazolides (N-acylimidazoles) of the formula I ##STR1## wherein R.sub.1 is methyl, ethyl or isopropyl,R.sub.2, R.sub.3 and R.sub.4 independently of one another are each hydrogen, methyl, ethyl or isopropyl, with the proviso that R.sub.2 is hydrogen only when R.sub.1 is isopropyl,R.sub.5, R.sub.6 and R.sub.7 independently of one another are each hydrogen, methyl, ethyl or isopropyl, or phenyl which is unsubstituted or substituted by methyl or ethyl groups, with the proviso that at least one of the symbols R.sub.5, R.sub.6 and R.sub.7 is phenyl which is unsubstituted or substituted according to definition.The imidazolides (I) are suitable as curing agents for polyepoxide compounds.

    摘要翻译: 描述了式I(I)的新型咪唑啉(N-酰基咪唑),其中R1是甲基,乙基或异丙基,R2,R3和R4彼此独立地是氢,甲基,乙基或异丙基,其中 条件是仅当R 1为异丙基时,R 2为氢,R 5,R 6和R 7彼此独立地为氢,甲基,乙基或异丙基,或未被取代或被甲基或乙基取代的苯基,条件是至少一个 符号R5,R6和R7是根据定义未取代或取代的苯基。 咪唑啉(I)适合作为聚环氧化物化合物的固化剂。

    Use of crystalline, crosslinked synthetic resins as a storage material
in latent heat stores
    53.
    发明授权
    Use of crystalline, crosslinked synthetic resins as a storage material in latent heat stores 失效
    使用结晶交联的合成树脂作为潜热储存中的储存材料

    公开(公告)号:US4259198A

    公开(公告)日:1981-03-31

    申请号:US965621

    申请日:1978-11-28

    CPC分类号: C09K5/063 C08L63/00 Y02B10/20

    摘要: The invention relates to the use of crystalline resins as storage material in latent heat accumulators. Crystalline synthetic resins replace the crystalline inorganic salt of the known latent heat reservoirs. Preferably epoxide resins, polyurethane resins and polyester resins, which contain very specific long-chain polyester molecule moieties, are used. The crystalline synthetic resins have one or more, preferably two, crystallite melt temperatures.

    摘要翻译: 本发明涉及结晶树脂作为潜热蓄热器中的储存材料的用途。 结晶合成树脂取代已知潜热储层的结晶无机盐。 优选使用含有非常特定的长链聚酯分子部分的环氧树脂,聚氨酯树脂和聚酯树脂。 结晶合成树脂具有一个或多个,优选两个微晶熔体温度。

    Power supply unit for signal luminaires
    55.
    发明授权
    Power supply unit for signal luminaires 有权
    用于信号灯的电源单元

    公开(公告)号:US09263914B2

    公开(公告)日:2016-02-16

    申请号:US13704340

    申请日:2011-05-21

    摘要: For signal luminaires which indicate the term STOP or DANGER upon activation, a circuit containing a first operating case feed unit and a second auxiliary source is provided for the purpose of supplying a reliable power supply. In this case, the second auxiliary source is inductively coupled to the signal luminaire electric circuit; while the signal luminaires are capacitively coupled to ground. The use of switches during operation in a fall-back level is obviated in this way.

    摘要翻译: 对于在激活时指示术语STOP或危险的信号灯具,提供包含第一操作箱馈送单元和第二辅助源的电路,用于提供可靠的电源。 在这种情况下,第二辅助源电感耦合到信号灯电路; 而信号灯具电容耦合到地。 以这种方式避免了在倒退级别的操作期间使用开关。

    7 α-hydroxysteroid dehydrogenase knockout mutants and use therefor
    56.
    发明授权
    7 α-hydroxysteroid dehydrogenase knockout mutants and use therefor 有权
    7α-羟基类固醇脱氢酶敲除突变体并用于此

    公开(公告)号:US09096825B2

    公开(公告)日:2015-08-04

    申请号:US13699239

    申请日:2011-05-27

    摘要: The invention relates to 12 α-hydroxysteroid dehydrogenases, nucleic acid sequences coding for the same, expression cassettes and vectors, recombinant microorganisms containing the corresponding coding nucleic acid sequences, a method for producing said 12 α-hydroxysteroid dehydrogenases, a method for enzymatic oxidation of 12 α-hydroxysteroids using said enzyme, a method for enzymatic reduction of 12-ketosteroids using said enzyme, a method for qualitative or quantitative determination of 12-ketosteroids and/or 12α-hydroxysteroids using said 12α-hydroxysteroid dehydrogenases and a method for production of ursodesoxycholic acid, comprising the enzyme-catalyzed cholic acid oxidation using said 12 α-hydroxysteroid dehydrogenases.

    摘要翻译: 本发明涉及12种α-羟基类固醇脱氢酶,编码相同的核酸序列,表达盒和载体,含有相应的编码核酸序列的重组微生物,所述12种α-羟基类固醇脱氢酶的制备方法, 使用所述酶的12种α-羟基类固醇,使用所述酶酶促还原12-酮类固醇的方法,使用所述12α-羟基类固醇脱氢酶定性或定量测定12-酮类和/或12α-羟基类固醇的方法及其制备方法 熊去氧胆酸,其包含使用所述12α-羟基类固醇脱氢酶的酶催化的胆酸氧化。

    SPECIFIC SALT, ANHYDROUS AND CRYSTALLINE FORM OF A DIHYDROPTERIDIONE DERIVATIVE
    57.
    发明申请
    SPECIFIC SALT, ANHYDROUS AND CRYSTALLINE FORM OF A DIHYDROPTERIDIONE DERIVATIVE 有权
    二盐酸盐衍生物的特殊盐,无机和结晶形式

    公开(公告)号:US20120214995A1

    公开(公告)日:2012-08-23

    申请号:US13457991

    申请日:2012-04-27

    IPC分类号: C07D475/06

    CPC分类号: C07D475/00

    摘要: The present invention relates to a specific salt of a dihydropteridione derivative, namely the trihydrochloride salt of the compound N-[trans-4-[4-(cyclopropylmethyl)-1-piperazinyl]cyclohexyl]-4-[[(7R)-7-ethyl-5,6,7,8-tetrahydro-5-methyl-8-(1-methylethyl)-6-oxo-2-pteridinyl]amino]-3-methoxy-benzamide, to its crystallisation in the form of an hydrate with water, to a process for the manufacture thereof, and to the use thereof in a pharmaceutical composition.

    摘要翻译: 本发明涉及二氢二萜二酮衍生物的具体盐,即化合物N- [反式-4- [4-(环丙基甲基)-1-哌嗪基]环己基] -4 - [[(7R)-7 - 乙基-5,6,7,8-四氢-5-甲基-8-(1-甲基乙基)-6-氧代-2-吖啶基]氨基] -3-甲氧基 - 苯甲酰胺,其结晶形式为 水合物,其制备方法及其在药物组合物中的用途。

    CRYSTALLINE FORM OF A DIHYDROPTERIDIONE DERIVATIVE
    59.
    发明申请
    CRYSTALLINE FORM OF A DIHYDROPTERIDIONE DERIVATIVE 有权
    二氢异氰酸酯衍生物的结晶形式

    公开(公告)号:US20100280037A1

    公开(公告)日:2010-11-04

    申请号:US12670714

    申请日:2008-08-01

    CPC分类号: C07D475/00

    摘要: The present invention relates to a crystalline form a dihydropteridione derivative, namely a crystalline form of the free base N-[trans-4-[4-(cyclopropylmethyl)-1-piperazinyl]cyclohexyl]-4-[[(7R)-7-ethyl-5,6,7,8-tetrahydro-5-methyl-8-(1-methylethyl)-6-oxo-2-pteridinyl]amino]-3-methoxy-benzamide, to a process for the manufacture thereof, and to the use thereof in a pharmaceutical composition.

    摘要翻译: 本发明涉及结晶形式的二氢啶二酮衍生物,即游离碱N- [反式-4- [4-(环丙基甲基)-1-哌嗪基]环己基] -4 - [[(R)-7- - 乙基-5,6,7,8-四氢-5-甲基-8-(1-甲基乙基)-6-氧代-2-蝶啶基]氨基] -3-甲氧基 - 苯甲酰胺制备其制备方法, 以及其在药物组合物中的用途。